Phathom Pharmaceuticals (PHAT) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.56
-1.29
-1.03
-0.76

Details

Expected EPS
-1.319876
Actual EPS
-1.56
Surprise EPS
-0.24
Surprise Percent
+18.19%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -1.56 per share for Q3 2024.

0 Comments

Share your thoughts